ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

New & Noteworthy – New York Times

Continue reading

2018-04-10 Michael Zand NEWS

Just How Smart Is Smart Medicine? MIT Scientists Are About To Find Out – Forbes


New York Times

New & Noteworthy
New York Times
… DANCES By Guido Maria Brera and Edoardo Nesi. Translated by Antony Shugaar. (Other, $18.95.) Nesi and Brera rail against globalization and its deleterious effects on a country like Italy. Nesi, who had to close his grandfather’s decades-old textile …

and more »

Continue reading

2018-04-10 Michael Zand NEWS

How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal – Investor’s Business Daily


Forbes

Just How Smart Is Smart Medicine? MIT Scientists Are About To Find Out
Forbes
We have smart phones, smart cars and now, with the advent of a new class of “living medicines,” we’re on the verge of having smart therapeutics. Synlogic, a Cambridge, Massachusetts-based MIT spin-out, is applying engineering principles to biology to …

Continue reading

2018-04-10 Michael Zand NEWS

How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal – Investor’s Business Daily


Life Sciences Intellectual Property Review

How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal
Investor’s Business Daily
The implications of Novartis’ deal for Spark are less clear. Spark is already partnered with Novartis on gene therapy Luxturna in Europe. Investors had been optimistic about the potential for a merger between Novartis and Spark. “We think investor …
Novartis to buy Avexis in $8.7 billion gene–therapy dealSFGate
Novartis signs $8.7bn gene therapy dealLife Sciences Intellectual Property Review
Novartis increases presence in gene therapy with AveXis acquisitionEPM Magazine
MENAFN.COM
all 45 news articles »
Continue reading

2018-04-10 Michael Zand NEWS

Medical breakthrough: Seattle man is first adult to get new gene therapy for vision – Medical Xpress


Life Sciences Intellectual Property Review

How These Gene Therapy Stocks Benefit From Novartis-AveXis Deal
Investor’s Business Daily
The implications of Novartis’ deal for Spark are less clear. Spark is already partnered with Novartis on gene therapy Luxturna in Europe. Investors had been optimistic about the potential for a merger between Novartis and Spark. “We think investor …
Novartis to buy Avexis in $8.7 billion gene–therapy dealSFGate
Novartis signs $8.7bn gene therapy dealLife Sciences Intellectual Property Review
Novartis increases presence in gene therapy with AveXis acquisitionEPM Magazine
MENAFN.COM
all 45 news articles »
Continue reading

2018-04-10 Michael Zand NEWS

Novartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billion – Chemical & Engineering News

Chemical & Engineering NewsNovartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billionChemical & Engineering NewsA cartoon illustrating the structure of AAV9, the virus AveXis uses to deliver its gene therapies into the brain a… Continue reading

2018-04-10 Michael Zand NEWS

Novartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billion – Chemical & Engineering News

Chemical & Engineering NewsNovartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billionChemical & Engineering NewsA cartoon illustrating the structure of AAV9, the virus AveXis uses to deliver its gene therapies into the brain a… Continue reading

2018-04-10 Michael Zand NEWS

AGTC completes enrollment in trial of X-linked retinoschisis gene therapy – Healio

registrarjournal.comAGTC completes enrollment in trial of X-linked retinoschisis gene therapyHealioThe open-label, dose escalation trial will assess the safety and efficacy of the adeno-associated virus-based gene therapy through intravitreal administr… Continue reading

2018-04-10 Michael Zand NEWS
  • 1
  • …
  • 271
  • 272
  • 273
  • 274
  • 275
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

The Daily Gazette

Medical breakthrough: Seattle man is first adult to get new gene therapy for vision
Medical Xpress
So Willis checked in with his eye doctor late last year, setting in motion a train of events that culminated March 20 at Children’s Hospital Los Angeles (CHLA) when he became the first adult to undergo the first gene therapy approved in the U.S. for …
Seattle man is first adult to get new gene therapy for vision | The …The Daily Gazette
Gene Therapy Prevents Vision Loss Caused by CLN6 Disease in Mouse StudyBatten Disease News
Otsuka and Takara team up to develop gene therapy candidates in oncologyThe Pharma Letter
Medgadget (blog) –Business Services –Healthcare Journal
all 12 news articles »